HOUSTON, Oct. 14, 2016 /PRNewswire/ -- Houston-based mass tort law firm Williams Kherkher announced today that they have appointed an attorney to investigate claims that teething tablets containing the known toxin belladonna may have harmed over 400 infants and may have directly caused 10 tragic deaths. The firm announced today that partner John Boundas will lead the investigation into these claims. In the announcement, attorney Boundas discussed the severity claims: "There have been reports of infant injuries and death after using Hyland tablets and gels. We are investigating to see if there may be a legal remedy for those affected."
On September 30th, the Food and Drug Administration issued a warning against homeopathic teething tablets and gels, such as those produced by Hyland's and possibly many others. The FDA warning urges consumers to immediately stop using these products, as they may pose a significant health risk to teething infants.
The FDA's Warning against Homeopathic Teething Remedies
While the FDA has issued a warning against giving homeopathic teething products to children, it has stopped short of recalling them completely. The warning it issued advises parents and caretakers who have been using these products to immediately seek medical attention if their child experiences any of the following:
- Difficulty breathing
- Difficulty urinating
- Muscle weakness
- Flushed skin
- Excessive sleepiness or lethargy
- Unusual agitation
In response to the warning the FDA issued, carriers of some of the affected homeopathic teething tablets and gels, including CVS, have voluntarily stopped sales of these products. Some of the products that have already been removed from store shelves include:
- Baby Orajel Naturals Tablets for Teething Pain, 125 Count
- Baby Orajel Naturals Gel for Teething Pain, .33 oz.
- Baby Orajel Naturals Gel for Teething Pain Nighttime Formula, .33 oz.
- Hyland's Baby Nighttime Teething Tablets, 135 Count
- Hyland's Baby Teething Tablets, 13 Count
- Hyland's Baby Teething Tablets, 135 Count
- Hyland's Baby Teething Gel, .5 oz.
- Hyland's Teething Gel, .33 oz.
- CVS Homeopathic Infants' Teething Liquid, .85 oz.
- CVS Homeopathic Infant's Teething Tablet, 135 Count
The active ingredient in many of these homeopathic teething relief products is belladonna, a plant whose toxicity has been known for centuries. The symptoms in children who have been given these teething tablets are consistent with those of belladonna toxicity. In light of the recent infant deaths and injuries that may very well be associated with the use of these homeopathic teething remedies, one of the affected manufacturers, Hyland's, has decided to stop marketing these products in the United States.
This is not the first time Hyland's has encountered trouble for its homeopathic teething medications. In 2010, the company issued a voluntary recall of these same products for the same concern about toxicity in infants. While belladonna can be safe in miniscule doses, the FDA's investigation at the time found that the teething tablets contained inconsistent amounts of belladonna and therefore could pose a serious risk to the infants they were given to.
As with any defective product, compensation may be available for the families of infants who have suffered serious adverse effects associated with belladonna toxicity. To learn more about the legal options available to families who have been hurt by homeopathic teething gels and tablets, contact Williams Kherkher at (888) 220-0640 to speak with an attorney.
About Williams Kherkher Hart Boundas Easterby, LLP
Williams Kherkher Hart Boundas Easterby, LLP is a nationally recognized trial law firm representing clients across the country in mass torts, personal injury, and commercial litigation. Williams Kherkher Hart Boundas Easterby, LLP welcomes the opportunity to work with other law firms in joint ventures.
Media Contact: Sean Hall, 1-800-267-1704, email@example.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/williams-kherkher-announces-counsel-for-infant-teething-product-investigation-300345341.html
SOURCE Williams Kherkher Hart Boundas Easterby, LLP